CrossrefInfokarte
Exploring Galectin-3 as an Emerging Frontier in Biomarker Research for Clinical Trials Approaching Cardiovascular Diseases
ACS Pharmacology & Translational Science · 2026-04-10 · 9 (4) · 771-783
DOI: 10.1021/acsptsci.5c00671 ↗Abstract
Kein Abstract verfügbar.
EUVIMED